Q4 2019 IGM Biosciences Inc Earnings Call Transcript
Good day, everyone, and welcome to the IGM Biosciences Fourth Quarter and Full Year 2019 Financial Results. Today's call is being recorded.
At this time, I would now like to turn the call over to Misbah Tahir, Chief Financial Officer of IGM.
Thank you, operator. Welcome, and thank you to those of you joining us today to discuss IGM's fourth quarter and full year 2019 financial results. With me this afternoon to discuss the financial results and to provide a general corporate update, are Fred Schwarzer, Chief Executive Officer; Bruce Keyt, Chief Scientific Officer; and Dan Chen, Chief Medical Officer.
Before we begin, please note that we will be making forward-looking statements on this call including statements about IGM's plans, expectations and forecasts and about future events. Actual results may differ materially as a result of various risks and uncertainties including those discussed in the company's most recent annual report on Form 10-K as well as its other filings with the SEC.
Any
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |